Stellantis reinstates guidance but flags ‘tough decisions’ after $1.7 billion tariff impact

Stellantis reinstates guidance but flags ‘tough decisions’ after .7 billion tariff impact


A new Jeep Wrangler 4-Door Sahara 4×4 vehicle displayed for sale at a Stellantis NV dealership in Miami, Florida, US, on Saturday, April 5, 2025.

Eva Marie Uzcategui | Bloomberg | Getty Images

Auto giant Stellantis on Tuesday reinstated its financial guidance and touted a gradual recovery over the coming months.

Stellantis, which owns household names including Jeep, Dodge, Fiat, Chrysler and Peugeot, reported a first-half net loss of 2.3 billion euros ($2.65 billion), compared to a net profit of 5.6 billion euros over the same period in 2024.

The multinational conglomerate had flagged the first-half loss in a surprise trading update last week, saying at the time that the move was necessary due to the difference between consensus forecasts and the firm’s performance.

Stellantis updated its full-year tariff impact to roughly 1.5 billion euros, of which 300 million euros was incurred during the first half of 2025.

New CEO Antonio Filosa, who officially took the top job last month, said in a call with analysts Tuesday that the automaker has been working with President Donald Trump’s administration since the tariffs were implemented. He said he wants the administration “to properly recognize the high American U.S. content in some vehicles” when it comes to duties.

He also said the company still has work to do in its key North American segment, which has been dealing with inventory issues and fractured relationships with employees and dealers.

“My first weeks as CEO have reconfirmed my strong conviction that we will fix what’s wrong in Stellantis by capitalizing on everything that’s right in Stellantis – starting from the strength, energy and ideas of our people, combined with the great new products we are now bringing to market,” Filosa said in a statement earlier Tuesday.

“2025 is turning out to be a tough year, but also one of gradual improvement,” Filosa said.

“Our new leadership team, while realistic about the challenges, will continue making the tough decisions needed to re-establish profitable growth and significantly improved results,” he added.

Looking ahead, the company re-established financial guidance for the second half. It expects to see increased net revenues, low-single-digit adjusted operating income profitability and improved industrial free cash flow over the coming months.

The automaker had suspended its guidance in April, citing uncertainties with tariffs.

Stellantis’ updated financial guidance was based on an assumption that current tariff and trade rules will remain in place.

It comes shortly after the U.S. and European agreed to a trade framework that means U.S. President Donald Trump’s administration will impose a blanket tariff of 15% on most EU goods.

The deal represents a significant reduction from Trump’s threat to impose charges of 30% from Aug. 1 and almost halves the existing tariff rate on Europe’s auto sector from 27.5%.

Automotive industry groups welcomed the breakthrough, particularly as it appears to avert a painful transatlantic trade war, but they also expressed deep concern about the costs associated with the new tariff reality.

Imports from Canada and Mexico are currently taxed at 25%, but Trump has threatened to hike duties on Mexico to 30% and Canada to 35% starting Aug 1.

Stellantis posted first-half net revenues of 74.3 billion euros, reflecting a 13% year-on-year drop, primarily driven by annual declines in North America, among other regions.

Filosa said the company would be bringing back popular nameplates that had been discontinued in the U.S. and launching new products in the coming months. He added that Stellantis would provide an updated business plan at its capital markets day early next year.

Milan-listed shares of Stellantis traded as much as 4.5% lower during morning deals before paring losses.



Source

Nine of the largest pharma companies ink deals with Trump to lower drug prices
World

Nine of the largest pharma companies ink deals with Trump to lower drug prices

President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals by 30% to 80% during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with […]

Read More
Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees
World

Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees

Sundar Pichai, chief executive officer of Alphabet Inc., during the Bloomberg Tech conference in San Francisco, California, US, on Wednesday, June 4, 2025. David Paul Morris | Bloomberg | Getty Images With the AI talent wars heating up between companies like OpenAI, Meta and Anthropic, one way Google has been competing is by aggressively rehiring […]

Read More
Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt
World

Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt

Chris Ratcliffe | Bloomberg | Getty Images Tween retailer Claire’s is facing legal challenges from some of its Asia-based suppliers over millions in unpaid debts as it tries to emerge from a second bankruptcy under new ownership, according to claims the suppliers filed in Hong Kong.  The clash with vendors comes as private equity firm […]

Read More